Biological
PPV-23 clinical trials
Also written PPV-23.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Westat (1) · Korea University Guro Hospital (1) · National Jewish Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
10-valent pneumococcal conjugate vaccine (1) · 13-valent pneumococcal vaccine (1)
Studies
Open first, then newest update. How each study uses PPV-23 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT01443117Written as PPV-23 Vaccine
- Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant WomenCompletedPhase 2WestatNCT02717494Written as PPV-23
- Pneumococcal Post-Vaccination TitersStatus unknownNot applicableNational Jewish HealthNCT02726347Written as PPV-23
- MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedPhase 4Korea University Guro HospitalNCT02225327Written as PPV23 alone